Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Rubicon"

1 News Found

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
News | April 16, 2026

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%